Ancef and Fragmin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ancef (cefazolin sodium) and Fragmin (dalteparin sodium). Common drug interactions include haematoma among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Ancef and Fragmin. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Ancef?

Ancef has active ingredients of cefazolin sodium. eHealthMe is studying from 3,292 Ancef users. Check the latest studies of Ancef.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.



On Jul, 07, 2026

36 people who take Ancef and Fragmin together, and have interactions are studied.

Ancef and Fragmin drug interactions.

What are the common drug interactions of Ancef and Fragmin, by gender? *:

female:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Abscess (pus)
  3. Abscess limb (limb infection)
  4. Colitis ulcerative (inflammation of colon with ulcer)
  5. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
  6. Infusion site erythema (reddening of the skin at infusion site)
  7. Infusion site oedema (swelling from excessive accumulation of watery fluid from infusion site)
  8. Infusion site pain
  9. Infusion site warmth
  10. Tooth abscess (pus formation in tooth)

male:

  1. Haemoglobin decreased
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Cellulitis (infection under the skin)
  4. Chronic kidney disease
  5. Constipation
  6. Haematocrit decreased
  7. Haemorrhage (bleeding)
  8. Hepatitis a
  9. Laboratory test abnormal
  10. Loss of consciousness

What are the common drug interactions of Ancef and Fragmin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cellulitis (infection under the skin)
  2. Loss of consciousness
  3. Respiratory depression (respiration has a rate below 12 breaths)
  4. Similar reaction on previous exposure to drug

30-39:

n/a

40-49:

  1. Haematoma (collection of blood outside the blood vessels)
  2. Abscess (pus)
  3. Abscess limb (limb infection)
  4. Colitis ulcerative (inflammation of colon with ulcer)
  5. Erythema nodosum (skin inflammation that results in reddish, painful, tender lumps most commonly located in the front of the legs below)
  6. Infusion site erythema (reddening of the skin at infusion site)
  7. Infusion site oedema (swelling from excessive accumulation of watery fluid from infusion site)
  8. Infusion site pain
  9. Infusion site warmth
  10. Tooth abscess (pus formation in tooth)

50-59:

  1. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  2. Alopecia (absence of hair from areas of the body)
  3. Anxiety
  4. Chronic kidney disease
  5. Emotional distress
  6. Pain
  7. Psychological trauma
  8. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)

60+:

  1. Haemoglobin decreased
  2. Hypotension (abnormally low blood pressure)
  3. Age indeterminate myocardial infarction (age indeterminate heart attack)
  4. Anuria (failure of the kidneys to produce urine)
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Asthenia (weakness)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Blood urine present
  9. Cardiac failure congestive
  10. Catheter related infection

What are the existing conditions these people have? *

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 18 people, 50.00%
  2. Abscess (pus): 18 people, 50.00%
  3. Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 15 people, 41.67%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 7 people, 19.44%
  5. High Blood Pressure: 4 people, 11.11%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.33%
  7. Gastric Ulcer (stomach ulcer): 3 people, 8.33%
  8. Gastric Disorder (disease of stomach): 3 people, 8.33%
  9. Traumatic Haemorrhage (a bleeding due to trauma): 2 people, 5.56%
  10. Pain: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ancef and Fragmin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ancef and Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ancef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ancef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fragmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and dalteparin sodium (the active ingredients of Ancef and Fragmin, respectively), and Ancef and Fragmin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: